Skip to content

Mofezolac

Drug profile

Also known as: N-22

PMDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Mofezolac is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including PTGS1, PTGS1 and PTGS2.

  • Molecular targets: PTGS1, PTGS1, PTGS2 and PTGS2 (4 listed in DrugCentral).
  • Molecular formula: C19H17NO5; molecular weight 339.35 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Prostaglandin G/H synthase 1PTGS1unknownIC50 8.85
Prostaglandin G/H synthase 1PTGS1unknownIC50 8.85
Prostaglandin G/H synthase 2PTGS2unknownIC50 6.36
Prostaglandin G/H synthase 2PTGS2unknownIC50 6.36

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—PMDA——

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Mofezolac is on its molecule page.

Molecular formulaC19H17NO5
Molecular weight339.35 g/mol
CAS number78967-07-4
InChIKeyDJEIHHYCDCTAAH-UHFFFAOYSA-N
PubChem CID4237
COC1=CC=C(C=C1)C1=NOC(CC(O)=O)=C1C1=CC=C(OC)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Mofezolac work?

Its molecular targets in DrugCentral include PTGS1, PTGS1, PTGS2 and PTGS2.

What is the chemical formula of Mofezolac?

Mofezolac has the molecular formula C19H17NO5 and a molecular weight of 339.35 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyPMDA
Targets4
Indications0
FormulaC19H17NO5
DrugCentral ID1829
Interactive profile